• LAST PRICE
    0.3768
  • TODAY'S CHANGE (%)
    Trending Down-0.0085 (-2.2061%)
  • Bid / Lots
    0.3937/ 4
  • Ask / Lots
    0.3961/ 1
  • Open / Previous Close
    0.3853 / 0.3853
  • Day Range
    Low 0.3690
    High 0.3897
  • 52 Week Range
    Low 0.2501
    High 0.9099
  • Volume
    264,683
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.3853
TimeVolumeIGC
09:32 ET176750.3862
09:37 ET36790.380355
09:46 ET128560.375
09:48 ET1000.375
09:50 ET14900.3874
09:51 ET27680.377549
09:53 ET5280.3701
09:55 ET1330.385
09:57 ET32390.3774
10:00 ET3640.377
10:02 ET3100.378449
10:04 ET22000.3701
10:06 ET22720.3701
10:08 ET1000.375
10:09 ET30000.3702
10:11 ET28880.3759
10:13 ET18920.371952
10:15 ET10000.3815
10:22 ET52000.3702
10:29 ET61080.3782
10:31 ET7000.3793
10:33 ET10000.3822
10:36 ET2000.3834
10:38 ET80000.3834
10:40 ET52000.389
10:42 ET10000.3857
10:45 ET1500.3897
10:49 ET10000.3897
10:51 ET1000.3897
11:00 ET1200.3853
11:03 ET1000.3896
11:12 ET2000.381
11:21 ET7000.380601
11:25 ET50000.3806
11:27 ET41300.3877
11:38 ET51400.3805
11:50 ET1310.3841
11:57 ET2600.3875
11:59 ET2400.387152
12:01 ET1000.382174
12:03 ET6150.3875
12:10 ET2500.3822
12:15 ET20000.3805
12:19 ET1030.3829
12:28 ET3000.3805
12:33 ET10000.3806
12:35 ET23760.3839
12:44 ET3000.3801
12:53 ET20000.3801
12:55 ET53790.376
12:57 ET60800.3761
01:02 ET1310.3799
01:04 ET10000.376
01:06 ET30790.376
01:08 ET31010.376
01:09 ET265950.3799
01:11 ET45220.3799
01:13 ET9060.376
01:20 ET14950.3755
01:24 ET1400.3799
01:27 ET1000.3798
01:38 ET1190.375501
01:40 ET1000.3798
01:45 ET1000.3776
01:51 ET2000.376
01:58 ET10000.376
02:02 ET20000.376
02:07 ET2000.3796
02:32 ET1050.3769
02:36 ET1580.3769
02:38 ET2930.3769
02:39 ET1420.3769
02:45 ET15250.377
02:52 ET1000.377
03:01 ET2000.3837
03:03 ET6000.377
03:21 ET10000.3837
03:26 ET26760.382
03:28 ET9000.3766
03:32 ET1000.3836
03:39 ET2000.3835
03:42 ET1000.3834
03:46 ET2650.3852
03:48 ET3600.3767
03:50 ET38490.3767
03:55 ET86920.3866
04:00 ET61500.3768
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIGC
IGC Pharma Inc
29.1M
-1.8x
---
United StatesLGVN
Longeveron Inc
29.1M
-0.2x
---
United StatesENLV
Enlivex Therapeutics Ltd
29.1M
-1.1x
---
United StatesCLCS
Cell Source Inc
28.9M
-4.0x
---
United StatesPLUR
Pluri Inc
26.5M
-1.1x
---
United StatesMIRA
Mira Pharmaceuticals Inc
28.1M
-2.2x
---
As of 2024-11-04

Company Information

IGC Pharma, Inc. is a clinical-stage company, which is engaged in developing treatments for Alzheimer’s disease. The Company’s flagship drug, IGC-AD1, is an investigational drug tackles agitation, a major burden for patients and caregivers by addressing neuroinflammation. The Company operates through two segments: Life Sciences Segment and Infrastructure Segment. Its TGR-63 has demonstrated its potential to disrupt the progression of Alzheimer’s by targeting Aβ plaques, a key disease hallmark. The Company’s IGC-1C represents a potential breakthrough by targeting tau protein and neurofibrillary tangles, aiming to modify the disease course. Its IGC-M3 focuses on early intervention by inhibiting Aβ plaque formation, potentially slowing cognitive decline. Its LMP is designed to target multiple hallmarks of Alzheimer’s disease, including Aβ plaques and neurofibrillary tangles for a comprehensive therapeutic effect. It seeks to leverage artificial intelligence (AI) for Alzheimer's research.

Contact Information

Headquarters
2405 York Road, Suite 201LUTHERVILLE-TIMONIUM, MD, United States 21093-2264
Phone
301-983-0998
Fax
240-465-0273

Executives

Independent Chairman of the Board
Richard Prins
President, Chief Executive Officer, Director
Ram Mukunda
Vice-President, Principal Financial Officer, Chief Compliance Officer, Director
Claudia Grimaldi
Independent Director
Terry Lierman
Independent Director
James Moran

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$29.1M
Revenue (TTM)
$1.1M
Shares Outstanding
75.6M
IGC Pharma Inc does not pay a dividend.
Beta
1.32
EPS
$-0.21
Book Value
$0.11
P/E Ratio
-1.8x
Price/Sales (TTM)
27.4
Price/Cash Flow (TTM)
---
Operating Margin
-1,261.77%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.